Aspen Pharmacare Holdings Limited

Johannesburg Stock Exchange APN.JO

Aspen Pharmacare Holdings Limited EBITDA Margin for the year ending June 30, 2024: 22.16%

Aspen Pharmacare Holdings Limited EBITDA Margin is 22.16% for the year ending June 30, 2024, a -5.07% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
  • Aspen Pharmacare Holdings Limited EBITDA Margin for the year ending June 30, 2023 was 23.34%, a -14.06% change year over year.
  • Aspen Pharmacare Holdings Limited EBITDA Margin for the year ending June 30, 2022 was 27.16%, a 18.33% change year over year.
  • Aspen Pharmacare Holdings Limited EBITDA Margin for the year ending June 30, 2021 was 22.95%, a 22.03% change year over year.
  • Aspen Pharmacare Holdings Limited EBITDA Margin for the year ending June 30, 2020 was 18.81%, a 31.86% change year over year.
Key data
Date EBITDA Margin EBIT Margin Depreciation and Amortization EBIT
Market news
Loading...
SV Wall Street
Johannesburg Stock Exchange: APN.JO

Aspen Pharmacare Holdings Limited

CEO Mr. Stephen Bradley Saad BCom, CA(SA)
IPO Date Jan. 4, 2000
Location South Africa
Headquarters Aspen Place
Employees 8,867
Sector Healthcare
Industries
Description

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. The company was founded in 1850 and is headquartered in Durban, South Africa.

Similar companies

WHL.JO

Woolworths Holdings Limited

USD 3.20

1.03%

SHP.JO

Shoprite Holdings Limited

USD 15.42

1.43%

MTN.JO

MTN Group Limited

USD 6.27

0.14%

FSR.JO

FirstRand Limited

USD 4.12

2.36%

SOL.JO

Sasol Limited

USD 4.43

-5.43%

StockViz Staff

February 7, 2025

Any question? Send us an email